摘要
食管癌常规放射治疗的长期生存率为4.3%～16.4%,80%以上的治疗失败是由于局部病灶未控或复发。非常规分割方法将食管癌放射治疗的5年生存率提高了15%以上,同期放化疗结合治疗食管癌也显示出其优势。治疗方案的个体化可进一步增加疗效,降低并发症,提高生活质量。生物学方法可能为非手术治疗食管癌个体化治疗方案的选择提供思路。
The long-term survival rate of esophageal carcinoma is 4. 3% - 16.4% after conventionally fractionated radiotherapy （CR） , which mainly results from local regional treatment failure and regional recurrence. Unconventional fractionation radiotherapy has increased the 5-year survival rate of esophageal carcinoma by 15%, while concurrent chemoradiotherapy also provides significant therapeutic benefits. Individualized treatment scheme may achieve more therapeutic benefits, reduce complications, and im- prove quality of life. Biological method may facilitate the choice of treatment scheme.
出处
《癌症进展》
2008年第1期30-35,52,共7页
Oncology Progress
基金
徐州市科技局资助项目
项目号:X2003024
关键词
食管癌
放射治疗
化学治疗
esophageal carcinoma radiothearpy chemothearpy
作者简介
通讯作者（Corresponding author），e—mail：ssp56@126．com
